AirSculpt TechnologiesvsAmgen

AIRS and AMGN stock compared: price, dividend, valuation and results, from SEC filings.

AIRS

AirSculpt Technologies, Inc.

$0.74

Value $52M

+5.57%
AIRS's page

AMGN

Amgen Inc.

$457.93

Value $247B

-0.95%
AMGN's page

AirSculpt Technologies (AIRS) has a market value of $52M and Amgen (AMGN) $247B. Over the last year, with dividends, AIRS moved -86.5% and AMGN +39.7%. Dividend yield: AIRS none, AMGN 2.17%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AIRS$52M

    AMGN$247B

    AMGN is 4,737 times AIRS

  • Revenue, 12 months

    AIRS$148M

    AMGN$38.9B

    AMGN is 263 times AIRS

  • Net income, 12 months

    AIRS-$9.4M

    AMGN$9.4B

  • Operating margin

    AIRS-4.7%

    AMGN32.4%

    37.1 points apart

  • ROIC

    AIRS-3.8%

    AMGN16.2%

    20.0 points apart

  • P/E

    AIRS–

    AMGN26.3

  • Dividend yield

    AIRS0.0%

    AMGN2.2%

    2.2 points apart

  • 5-year return

    AIRS-95.2%

    AMGN+158.3%

    253.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AIRS-95.2%

AMGN+158.3%

010020020222023202420252026
Returns by period
PeriodAIRSWith dividendsAMGNWith dividends
1 year since November 14, 2025-86.5%Price -86.5%+39.7%Price +36.0%
3 years since November 17, 2023-85.0%-46.9% a yearPrice -85.0%+87.3%+23.3% a yearPrice +72.5%
5 years since November 16, 2021-95.2%-45.6% a yearPrice -95.4%+158.3%+20.9% a yearPrice +123.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AIRSAirSculpt TechnologiesAMGNAmgen

Valuation

AIRSAMGN
Valuation
Price$0.74$457.93
Market value$52M$247B
Enterprise value (EV)$74M$288B
P/E–26.3
P/E, 5-year median–23.0
P/B0.517.2
EV/EBIT–22.8
Free cash flow yield–3.9%

Results and growth

AIRSAMGN
Results and growth
Revenue, 12 months$148M$38.9B
Net income, 12 months-$9.4M$9.4B
Free cash flow, 12 months-$2.5M$9.6B
Earnings per share, 12 months-$0.12$17.25
Revenue growth, year on year-15.8%10.0%
Revenue growth a year, past+19.3%over 5 years+7.6%over 5 years
EPS growth a year, past–+2.9%over 5 years

Margins and returns on capital

AIRSAMGN
Margins and returns on capital
Gross margin60.2%70.9%
Operating margin-4.7%32.4%
Net margin-6.4%24.1%
ROIC-3.8%16.2%
ROE-9.8%87.8%

Balance sheet

AIRSAMGN
Balance sheet
Cash$15M$13.2B
Total debt$65M$54.0B
Net debt / EBITDA3.72.3
Interest cover-1.4×4.8×

Dividends and buybacks

AIRSAMGN
Dividends and buybacks
Dividend yield–2.2%
Dividend per share, 12 months–$9.94
Dividend growth a year, past–+8.1%over 5 years
Buyback yield––
Shareholder yield–2.2%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AIRS or AMGN

Didn't find what you were looking for?

Ask us
Which is bigger, AirSculpt Technologies or Amgen?

By market value, Amgen ($247B) is about 4,737.0 times AirSculpt Technologies ($52M), at today's prices.

How did AIRS and AMGN stock do over the last 5 years?

Since November 16, 2021, AIRS's price moved -95.4% and AMGN's +123.0%. With dividends: AIRS -95.2% (-45.6% a year), AMGN +158.3% (+20.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, AIRS or AMGN?

The dividend yield at today's price is none for AirSculpt Technologies and 2.17% for Amgen. Over the last twelve months they paid – and $9.94 per share.

Which has the higher profit margins, AirSculpt Technologies or Amgen?

Over the last twelve months, the net margin was -6.4% for AirSculpt Technologies and 24.1% for Amgen, and the operating margin -4.7% and 32.4%. Revenue was $148M and $38.9B.

Which is the better investment, AirSculpt Technologies or Amgen?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.